Michelle E Kimple
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 04, 2024
Gαz-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice.Rachel J Fenske, Haley N Wienkes, Darby C Peter
|Mar 13, 2024
The prostaglandin E2 EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity.Joshua C Neuman, Austin Reuter, Kathryn A Carbajal
|Mar 14, 2023
Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort.Benjamin Wancewicz, Yanlong Zhu, Rachel J Fenske
|Aug 23, 2021
Human Islet Expression Levels of Prostaglandin E2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity.Nathan A Truchan, Rachel J Fenske, Harpreet K Sandhu
|Jul 07, 2021
Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance.Jaclyn A Wisinski, Austin Reuter, Darby C Peter
|Mar 11, 2021
Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion.Harpreet K Sandhu, Joshua C Neuman, Michael D Schaid
Pageof 1
